المؤلفون: Fleming, ND, Ramirez, PT, Soliman, PT, Schmeler, KM, Chisholm, GB, Nick, AM, Westin, SN, Frumovitz, M

المصدر: In Gynecologic Oncology December 2016 143(3):596-603

المؤلفون: How JA; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jahow@mdanderson.org., Dang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee S; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fellman B; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shafer A; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhao L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Celestino J; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hajek R; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morgan MB; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Laberiano Fernandez CD; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arrechedera CA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Solis Soto LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schmeler KM; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nick A; Texas Oncology, Houston, TX, USA., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Coleman R; Texas Oncology, Houston, TX, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: aajazaeri@mdanderson.org.

المصدر: Med (New York, N.Y.) [Med] 2024 Aug 10. Date of Electronic Publication: 2024 Aug 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE

المؤلفون: Knisely A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. nfleming@mdanderson.org.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2024 Aug; Vol. 31 (8), pp. 4855-4857. Date of Electronic Publication: 2024 Jun 05.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Venous Thromboembolism*/prevention & control , Venous Thromboembolism*/etiology , Pyridones*/therapeutic use , Pyrazoles*/therapeutic use , Postoperative Complications*/prevention & control , Genital Neoplasms, Female*/surgery , Factor Xa Inhibitors*/therapeutic use, Humans ; Female ; Gynecologic Surgical Procedures/adverse effects ; Prognosis

المؤلفون: Huepenbecker SP; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meyer LA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Iniesta MD; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chisholm GB; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Taylor JS; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wilke RN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: nfleming@mdanderson.org.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Jul 22; Vol. 189, pp. 80-87. Date of Electronic Publication: 2024 Jul 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

المؤلفون: Wagner P; Department of Surgical Oncology, Allegheny Healthy Network Cancer Institute, Pittsburgh, PA, USA., Levine EA; Department of Surgical Oncology, Atrium Health Wake Forest Baptist, Wake Forest University, Winston-Salem, NC, USA., Kim AC; Division of Surgical Oncology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, USA., Shen P; Department of Surgical Oncology, Atrium Health Wake Forest Baptist, Wake Forest University, Winston-Salem, NC, USA., Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Houston, TX, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Houston, TX, USA., Berry LK; Department of Gynecologic Oncology, Atrium Health Wake Forest Baptist, Wake Forest University, Winston-Salem, NC, USA., Karakousis GC; Division of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Tanyi JL; Department of Obstetrics and Gynecology Hospital, University of Pennsylvania, Philadelphia, PA, USA., Olson MT; OncoNano Medicine, Inc, Southlake, TX, USA., Madajewski B; OncoNano Medicine, Inc, Southlake, TX, USA., Ostrander B; OncoNano Medicine, Inc, Southlake, TX, USA., Krishnan K; OncoNano Medicine, Inc, Southlake, TX, USA., Balch CM; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Bartlett DL; Department of Surgical Oncology, Allegheny Healthy Network Cancer Institute, Pittsburgh, PA, USA. david.bartlett@ahn.org.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2024 Jul; Vol. 31 (7), pp. 4743-4744.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Peritoneal Neoplasms*/secondary , Peritoneal Neoplasms*/surgery , Cytoreduction Surgical Procedures*, Humans ; Hydrogen-Ion Concentration ; Prognosis ; Neoplasm, Residual

المؤلفون: Wagner P; Department of Surgical Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA., Levine EA; Department of Surgical Oncology, Atrium Health Wake Forest Baptist, Wake Forest University, Winston-Salem, NC, USA., Kim AC; Division of Surgical Oncology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, USA., Shen P; Department of Surgical Oncology, Atrium Health Wake Forest Baptist, Wake Forest University, Winston-Salem, NC, USA., Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Houston, TX, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Houston, TX, USA., Berry LK; Department of Gynecologic Oncology, Atrium Health Wake Forest Baptist, Wake Forest University, Winston-Salem, NC, USA., Karakousis GC; Division of Endocrine and Oncologic Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Tanyi JL; Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Olson MT; OncoNano Medicine, Inc, Southlake, TX, USA., Madajewski B; OncoNano Medicine, Inc, Southlake, TX, USA., Ostrander B; OncoNano Medicine, Inc, Southlake, TX, USA., Krishnan K; OncoNano Medicine, Inc, Southlake, TX, USA., Balch CM; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Bartlett DL; Department of Surgical Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. david.bartlett@ahn.org.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2024 Jul; Vol. 31 (7), pp. 4726-4734. Date of Electronic Publication: 2024 Apr 15.

نوع المنشور: Journal Article; Multicenter Study; Clinical Trial, Phase II

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Peritoneal Neoplasms*/secondary , Peritoneal Neoplasms*/diagnostic imaging , Cytoreduction Surgical Procedures* , Neoplasm, Residual* , Indocyanine Green*/administration & dosage, Humans ; Female ; Middle Aged ; Male ; Aged ; Hydrogen-Ion Concentration ; Prognosis ; Adult ; Follow-Up Studies ; Fluorescent Dyes/administration & dosage

المؤلفون: Wilke RN; The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: rnitecki@mdanderson.org., Iniesta MD; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Fellman B; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jazaeri AA; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Meyer LA; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Fleming ND; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Schmeler KM; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Taylor JS; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Jun 29; Vol. 188, pp. 120-124. Date of Electronic Publication: 2024 Jun 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

المؤلفون: Keating MF; Department of Chemistry, University of Texas at Austin, Austin, Texas 78712, United States.; Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, United States., Wolfe CA; Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, United States., Liebenberg K; Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, United States., Montgomery A; Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, United States., Porcari AM; Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, United States.; MS4Life Laboratory of Mass Spectrometry, Health Sciences Postgraduate Program, Universidade São Francisco, Bragança Paulista, SP 12916-900, Brazil., Fleming ND; Department of Surgery, MD Anderson Cancer Center, Houston, Texas 77030, United States., Makarov A; Thermo Fisher Scientific, 28199 Bremen, Germany., Eberlin LS; Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, United States.

المصدر: Analytical chemistry [Anal Chem] 2024 May 28; Vol. 96 (21), pp. 8234-8242. Date of Electronic Publication: 2024 May 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 0370536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6882 (Electronic) Linking ISSN: 00032700 NLM ISO Abbreviation: Anal Chem Subsets: MEDLINE

مواضيع طبية MeSH: Electric Power Supplies*, Humans ; Mass Spectrometry/methods ; Female ; Ovarian Neoplasms/surgery

المؤلفون: Knisely A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Iniesta MD; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Batman S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meyer LA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cain KE; Division of Pharmacy, Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Marten C; Division of Pharmacy, Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chisholm G; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schmeler KM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Taylor JS; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: nfleming@mdanderson.org.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Apr; Vol. 183, pp. 120-125. Date of Electronic Publication: 2024 Feb 16.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Pyridones*/administration & dosage , Pyridones*/adverse effects , Pyridones*/therapeutic use , Venous Thromboembolism*/prevention & control , Venous Thromboembolism*/etiology , Pyrazoles*/adverse effects , Pyrazoles*/administration & dosage , Pyrazoles*/therapeutic use , Genital Neoplasms, Female*/surgery , Feasibility Studies* , Postoperative Complications*/prevention & control , Enoxaparin*/administration & dosage , Enoxaparin*/adverse effects , Enoxaparin*/therapeutic use, Humans ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Gynecologic Surgical Procedures/adverse effects ; Gynecologic Surgical Procedures/methods ; Factor Xa Inhibitors/administration & dosage ; Factor Xa Inhibitors/adverse effects ; Factor Xa Inhibitors/therapeutic use ; Cohort Studies ; Adult ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Anticoagulants/therapeutic use

المؤلفون: Hinchcliff EM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Knisely A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Adjei N; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fellman B; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Xu C; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shafer A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gershenson DM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vikram R; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bathala T; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vining D; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ganeshan DM; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sun CC; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Meyer LA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Cancer [Cancer] 2024 Apr 01; Vol. 130 (7), pp. 1061-1071. Date of Electronic Publication: 2023 Nov 27.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Ovarian Neoplasms*/drug therapy , Antibodies, Monoclonal* , Antibodies, Monoclonal, Humanized*, Humans ; Female ; Bayes Theorem ; Immune Checkpoint Inhibitors